UK biotech startup Invizius develops second generation therapies to treat dysregulated illnesses such as kidney diseases.

Søren Møller, managing investment director of Novo Seeds, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Vijay Patel, managing partner of CVS Health Ventures, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Chris Picariello, president of Johnson & Johnson Innovation – JJDC, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Dan Reed, managing director of American Family Ventures, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Brad Robling, vice president of Lilly New Ventures, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Douglas Russell, managing director and head of MassMutual Ventures, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Jeffery Smith, director of equity and venture capital at Bristol Myers Squibb, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Bill Taranto, president of both MSD Global Health Innovation Fund and MSD Global Health Private Equity, is one of the 100 leading corporate venturing professionals in our Powerlist this year.

Laura Veroneau, managing partner of Optum Ventures, is one of the 100 leading corporate venturing professionals in our Powerlist this year.